Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atuna racemosa is a fruit-bearing tree in the Chrysobalanaceae family, native to Southeast Asia and the Pacific Islands. Traditionally used in regions such as Indonesia and Samoa for culinary purposes and as a remedy for inflammation, fever, diarrhea, hypertension, and severe abdominal pain[2][8][9]. Extracts from various parts of the plant (kernel/nut, bark, leaves) have demonstrated antibacterial activity—particularly against antibiotic-resistant bacteria like Methicillin-resistant Staphylococcus aureus (MRSA)—as well as antioxidant properties[2][4][5][8]. Key active compounds include 4’-O-methyl-ent-gallocatechin and (+)-gallocatechin; catechins such as epigallocatechin gallate may inhibit bacterial biofilm formation by targeting penicillin-binding protein 2a (PBP2a)[5]. Phytochemical screening reveals the presence of flavonoids, saponins, tannins (noted for antimicrobial/antioxidant effects), alkaloids, and steroids[6][8]. Toxicity studies indicate some cytotoxic potential but also suggest that hepatocytes can detoxify extracts in vitro; traditional use reports little indication of toxicity[3][7]. The plant is under investigation as a novel source of antibacterial/antibiofilm agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on atuna racemosa.